ScoreRheumatology, allergy and dermatology

PEN-FAST (penicillin allergy)

Estimates the probability that a reported penicillin allergy is confirmed on testing.

Updated 30 October 2026

When to use it

Adults labelled as penicillin-allergic, to choose between a direct oral challenge and allergy referral.

Warning

With a history of severe cutaneous adverse reaction (SJS/TEN, DRESS, AGEP) a drug challenge must not be performed, whatever the score.

What it needs

  • Reaction 5 years ago or less (or unknown)Yes or no
  • Anaphylaxis or angioedemaYes or no
  • Severe cutaneous adverse reaction (SJS/TEN, DRESS, AGEP)Yes or no
  • The reaction required treatment (or unknown)Yes or no

The points for each answer and the automatic total are in the app.

How to interpret it

PEN-FAST score
ResultInterpretation
≤ 0Very low risk (< 1 % positive tests)
1–2Low risk (≈ 5 %): candidate for a direct oral challenge
3Moderate risk (≈ 20 %): refer for allergy testing
≥ 4High risk (≈ 50 %): refer for allergy testing

Practical tip

A score < 3 identifies patients with very few positive tests (≈ 4 %); in the PALACE trial a direct oral challenge in this group was as safe as skin-test-guided care.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top